In support of a tumor suppressor function for SIRT3, it has also been reported previously that SIRT3−/− cells displayed elevated ability to form tumors in a xenograft model and loss of SIRT3 has been identified as a frequent event in breast cancer cases [45, 46]. This evidence concerns the gene SIRT3 and breast carcinoma.